Alopecia areata is an autoimmune disease that causes varying degrees of hair loss. The condition has significant ramifications for an individual's well being and quality of life.
The Alopecia Areata Symptom Impact Scale (AASIS) is a disease-specific patient-reported outcomes measure that asks participants about symptoms related to alopecia areata and how these symptoms interfere with daily functioning.
|AASIS Symptom Items||AASIS Interference Items|
|Loss of scalp hair||Work|
|Loss of body hair or eyelashes||Enjoyment of life|
|Tingling/numbness of scalp||Interaction with others|
|Itchy or painful skin||Daily activities|
|Irritated skin||Sexual relationships|
|Feeling anxious or worried||Quality of life|
Order the Alopecia Areata Symptom Impact Scale
Use our convenient online form to order the AASIS for use in your clinical research, clinical practice, funded and non-funded academic research, commercial research, or reproduction in educational materials or other publications.
- Purpose: To assess the severity of alopecia areata-related symptoms and the impact of these symptoms on daily functioning
- Population: Patients with alopecia areata
- Assessment Areas: Severity of symptoms and the impact of these symptoms on daily functioning in the past 24 hours
- Method: Self-report, interview with research staff, or electronic data entry
- Time required: Five minutes
- Scoring: A global symptom score can be obtained by averaging all symptoms items on the AASIS
- Reliability: Cronbach alpha reliability ranges from 0.77 to 0.93
Mendoza TR, Osei J, Duvic M. The utility and validity of the Alopecia Areata Symptom Impact Scale in measuring disease-related symptoms and their effect on functioning. J Investig Dermatol Symp Proc 19(1): S41-S46, 1/2018.
Mendoza TR, Osei JS, Shi Q, Duvic M. Development of the alopecia areata symptom impact scale. J Investig Dermatol Symp Proc 16(1): S51-S52, 12/2013.